Breaking South Korea and U.S. Troops to Commence Annual Joint Military Drills Amid North Korean Missile Activity Andy Green Aims for New Land Speed Record with Hydrogen-Powered Vehicle New Zealand Electoral Commission Urges Voter Registration Ahead of Deadline Fashion Retailers Embrace Repair Services and Workshops to Attract Sustainability-Conscious Gen Z Asian Shares Mixed as Nikkei Leads Gains; Oil Prices Rise

Monday August 10, 2026

Reporter

NanoViricides

2Articles Published

5Communities Covered

Published Articles

Press Release

As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo

Jul 13

Press Release

Research Analyst Report on NanoViricides Rates Company “Outperform”; Separately, A “Fireside Chat” Interview of the Company’s President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily

Jul 8